ASBPW
Aspire-Lakewood Holdings, Inc.
Key Financials
Revenue
$91457
N/A
Gross Profit
$-116
N/A
Net Income
$-24480848
↓ 95.3%
Total Liabilities
$7.7M
↓ 50.8%
Cash & Equivalents
$12.2M
N/A
Operating Income
$-19351291
↓ 1498.1%
EPS (Diluted)
$-16.38
↓ 762.1%
Shareholders' Equity
$-6376329.00
↑ 59.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/29/2026 | View on SEC |
| 8-K | 9/9/2026 | View on SEC |
| 8-K | 9/8/2026 | View on SEC |
| 8-K | 8/19/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| SCHEDULE 13G | 8/10/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| SCHEDULE 13G/A | 8/6/2026 | View on SEC |
| 8-K | 7/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ASBPW |
| Company Name | Aspire-Lakewood Holdings, Inc. |
| CIK | 1847345 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 561-704-8527 |